Join Zoom Meeting
https://mc-meet.zoom.us/j/95869608121?pwd=NG9GaG5JWE44eGpSckdRWHFSNnVkUT09
 
Meeting ID: 958 6960 8121
Passcode: 636276

Behavioral
Ronald Petersen, M.D., Ph.D.
"Alzheimer’s Disease 2024: New Criteria"

Learning Objectives:
Upon conclusion of this activity, participants will be able to:

• Translate the 2024 Alzheimer’s disease criteria into clinical practice
• Recognize the role of biomarkers in diagnosing Alzheimer’s disease

Dr. Petersen has the following relevant financial relationships to disclose: Consulting: Roche, Inc.; Genentech, Inc.; Eli Lilly and Co.; Nestle, Inc.; Eisai, Inc. and Other: Oxford University Press UpToDate and Dr. Petersen does not intend to discuss any off-label/investigative use of Pharmaceuticals or Instruments. 

Clifford R. Jack, Jr., M.D.
"Alzheimer’s Disease 2024: New Criteria"

Learning Objectives:
Upon conclusion of this activity, participants will be able to:

• Translate the 2024 Alzheimer’s disease criteria into clinical practice
• Recognize the role of biomarkers in diagnosing Alzheimer’s disease
• Recognize the controversies around the criteria

Dr. Jack does have the following relevant financial relationship to disclose: Grant/Research: NIH and does not intend to discuss any off-label/investigative use of Pharmaceuticals or Instruments.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.